1 documents found
Information × Registration Number 0204U006102, 0103U008532 , R & D reports Title Study of PAR-3 Expression and Function in Human Lymphocytes Using Blocking Cleavage Site-specific antibodies popup.stage_title Head Skok V.W., Registration Date 15-07-2004 Organization A.V.Palladin Institute of Biochemistry of National Academy of Sciences popup.description2 Polyclonal and monoclonal antibodies against 31-47 fragment of human PAR-3 have been obtained. The antibodies were shown to recognize 31-47 peptide conjugated to a protein carrier both in immunoenzyme assay and in Western blot. The antibodies also bound with malignant mouse lymphocytes and human peripheral blood lymphocytes. They demonstrated functional activity in vivo by increasing the contents of soluble fibrin and active thrombin in the blood plasma of immunized animals. The data obtained indicate for the presence of PAR-3 in the lymphocytes and for its influence on the blood coagulation system. Product Description popup.authors popup.nrat_date 2020-04-02 Close
R & D report
Head: Skok V.W.. Study of PAR-3 Expression and Function in Human Lymphocytes Using Blocking Cleavage Site-specific antibodies. (popup.stage: ). A.V.Palladin Institute of Biochemistry of National Academy of Sciences. № 0204U006102
1 documents found

Updated: 2026-03-24